Detalhe da pesquisa
1.
Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.
Clin Infect Dis
; 67(2): 193-201, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415190
2.
Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848011
3.
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
Clin Infect Dis
; 62(8): 1036-1042, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26797214
4.
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
Clin Infect Dis
; 62(4): 440-447, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503379
5.
Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.
Circulation
; 134(23): 1909-1911, 2016 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27920076
6.
Pioglitazone for Hepatic Steatosis in HIV/Hepatitis C Virus Coinfection.
AIDS Res Hum Retroviruses
; 31(10): 961-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214341
7.
Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone.
J Acquir Immune Defic Syndr
; 63(3): 355-61, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23535292